Source: Virtual Congress 2021 – Patient-reported outcome measures (PROMs): easy tools in the management of chronic respiratory diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Soler-Cataluña (Valencia, Spain), A. Huerta (Barcelona, Spain), P. Almagro (Terrassa, Barcelona, Spain), D. González-Segura (Barcelona, Spain), B. G Cosío (Palma de Mallorca, Balearic Islands, Spain). Prevalence of Poor Disease Control in Patients with severe COPD according to GOLD 2021. 1589

Member's Comments

No comment yet.

Related content which might interest you: Disease severity in COPD patients Source: Annual Congress 2003 - Staging and outcome in COPD Year: 2003 Level of control of Chronic Obstructive Pulmonary Disease according to clinical phenotypes. Study SINCON Source: International Congress 2017 – What is new in COPD diagnosis and classification? Year: 2017 Do GOLD stages of COPD severity really correspond to differences in health status? Source: Eur Respir J 2003; 22: 444-449 Year: 2003 Mechanisms of exercise intolerance in Global Initiative for Chronic Obstructive Lung Disease grade 1 COPD Source: Eur Respir J 2014; 44: 1177-1187 Year: 2014 The Impact of Multimorbidity on Hospitalizations in Patients with Chronic Obstructive Pulmonary Disease (COPD): a Population-Based Study Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Physical activity and symptom burden in COPD: The Canadian Cohort Obstructive Lung Disease (CanCOLD) study Source: Virtual Congress 2021 – Lung disease burden and management Year: 2021 Applying the ESPEN definition of Malnutrition in patients with stable Chronic Pulmonary Obstructive Disease: associations with Mortality and Healthcare use at 2 years Source: International Congress 2018 – Aspects of pulmonary rehabilitation and chronic care Year: 2018 “Asthma-like features” in Chronic Obstructive Pulmonary Disease (COPD) patients Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS) Year: 2018 Does Nutritional Risk Screening 2002 correlate with  dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study. Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Late Breaking Abstract - Disease trajectories in GOLD B chronic obstructive pulmonary disease (COPD) patients  – nationwide data from Denmark Source: Virtual Congress 2021 – COVID - 19, smoking and e-cigarettes Year: 2021 COPD: CardiOPulmonary Disease? Source: Eur Respir J 2013; 41: 1241-1243 Year: 2013 Study to Evaluate Satisfaction with the Inhalation Device Used by Patients with Asthma or Chronic Obstructive Pulmonary Disease and the Association with Adherence and Disease Control Source: Virtual Congress 2020 – Novel insights into nursing interventions for managing patients with asthma and COPD Year: 2020 Assessment of patients with COPD according to previous and new GOLD: Which stage in which group? Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014 Comparison of Eosinophilic and Non-eosinophilic Cases with Chronic Obstructive Pulmonary Disease (COPD) in terms of Clinical Arrival, Exacerbations, Quality of Life and Response to Treatment: A Prospective Study Source: International Congress 2019 – Airway diseases and blood cells Year: 2019 Adherence to pharmacotherapy of Colombian patients with COPD according to GOLD 2019 Source: Virtual Congress 2020 – Epidemiology and understanding of airways diseases in primary care Year: 2020 Undiagnosed COPD in adults 40 years and older: Reports from the Tunisian Population-Based Burden of Obstructive Lung Disease Study Source: Virtual Congress 2021 – COPD burden, epidemiology and management Year: 2021 The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014 Short telomere length and its association with risk for COPD and emphysema severity: Korean Obstructive Lung Disease (KOLD) cohort study Source: International Congress 2017 – Markers of COPD progression Year: 2017 Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint Source: International Congress 2014 – Clinical assessment of airway diseases Year: 2014 Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease: the GOLD science committee report 2019 Source: Eur Respir J, 53 (5) 1900164; 10.1183/13993003.00164-2019 Year: 2019